Lung Cancer

Top Story

Thermal ablation effective in early-stage lung cancer

November 14, 2018
Meeting News

Adverse effects from certain immunotherapies may be more common than initially reported

November 13, 2018
Adverse events associated with immune checkpoint inhibitors may be more common than reported in trials that led to FDA approvals of those agents, according to a study…
Meeting NewsPerspective

New physical activity guidelines encourage movement ‘anytime, anywhere’

November 12, 2018
CHICAGO — At the American Heart Association Scientific Sessions, HHS released the second edition of the Physical Activity Guidelines for Americans, which provides…

New biomarkers and therapeutic target discoveries in molecular oncology

HemOnc Today, November 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
A number of significant advances in molecular oncology have come to light in recent weeks, providing new knowledge for understanding immunotherapy response, immune…
More Headlines »

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers
Discoveries from ASCO Lung Cancer

Discoveries from ASCO Lung Cancer


Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »